US Stock MarketDetailed Quotes

BMRN Biomarin Pharmaceutical

Watchlist
  • 81.023
  • -1.108-1.35%
Trading Apr 30 13:57 ET
15.38BMarket Cap76.44P/E (TTM)

Biomarin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
8.79%648.83M
15.42%2.42B
20.22%646.21M
15.04%581.33M
11.52%595.28M
14.84%596.42M
13.53%2.1B
19.50%537.54M
23.63%505.34M
6.40%533.8M
Operating revenue
8.79%648.83M
15.42%2.42B
20.22%646.21M
15.04%581.33M
11.52%595.28M
14.84%596.42M
13.53%2.1B
19.50%537.54M
23.63%505.34M
6.40%533.8M
Cost of revenue
-7.60%125.18M
6.45%514.85M
6.43%135.48M
7.27%124.75M
4.03%128.08M
15.82%135.47M
2.80%483.67M
6.30%127.29M
12.32%116.29M
-3.10%123.13M
Gross profit
13.60%523.65M
18.11%1.9B
24.49%510.73M
17.36%456.58M
13.76%467.19M
14.55%460.94M
17.20%1.61B
24.29%410.25M
27.47%389.06M
9.62%410.67M
Operating expense
11.71%445.19M
11.48%1.75B
14.35%496.45M
10.37%431.01M
10.17%408.32M
7.40%398.54M
8.02%1.57B
10.11%434.15M
9.52%390.53M
2.72%370.62M
Selling and administrative expenses
7.05%225.91M
9.75%937.3M
11.93%275M
3.32%224M
9.40%215.34M
8.43%211.02M
12.46%854M
12.91%245.7M
18.28%216.8M
6.86%196.84M
-Selling and marketing expense
----
8.46%488.4M
6.90%133.2M
9.52%121.9M
5.67%115.6M
----
11.16%450.3M
10.17%124.6M
14.74%111.3M
8.42%109.4M
-General and administrative expense
----
11.20%448.9M
17.09%141.8M
-3.22%102.1M
14.07%99.74M
----
13.94%403.7M
15.89%121.1M
22.25%105.5M
4.96%87.44M
Research and development costs
19.29%204.99M
14.96%746.77M
19.39%206.25M
21.22%191.31M
12.12%177.36M
6.85%171.85M
3.31%649.61M
7.24%172.75M
-0.03%157.83M
-1.81%158.19M
Depreciation amortization depletion
-8.76%14.3M
-0.96%62.2M
-3.18%15.2M
-1.26%15.7M
0.19%15.62M
0.37%15.67M
1.45%62.8M
0.64%15.7M
3.25%15.9M
0.61%15.6M
-Depreciation and amortization
-8.76%14.3M
-0.96%62.2M
-3.18%15.2M
-1.26%15.7M
0.19%15.62M
0.37%15.67M
1.45%62.8M
0.64%15.7M
3.25%15.9M
0.61%15.6M
Operating profit
25.73%78.46M
243.96%158.1M
159.74%14.28M
1,835.91%25.57M
46.98%58.87M
99.20%62.4M
161.84%45.96M
62.79%-23.9M
97.13%-1.47M
189.73%40.05M
Net non-operating interest income expense
91.97%15.82M
1,886.63%41M
134.97%11.95M
3,637.81%11.96M
754.14%8.86M
514.90%8.24M
142.51%2.06M
341.98%5.08M
115.66%320K
-307.03%-1.35M
Non-operating interest income
62.15%19.37M
223.49%58.34M
107.16%18.04M
214.86%15.74M
403.47%12.61M
556.21%11.94M
72.05%18.03M
399.14%8.71M
173.62%5M
-43.97%2.51M
Non-operating interest expense
-4.21%3.55M
8.87%16.74M
81.47%5.5M
-19.23%3.78M
-2.69%3.76M
-2.71%3.7M
4.29%15.38M
-6.76%3.03M
20.90%4.68M
1.10%3.86M
Total other finance cost
----
0.17%594K
----
----
----
----
0.00%593K
----
----
----
Other net income (expense)
181.13%11.27M
-110.38%-10.54M
-643.56%-6.84M
672.42%4.05M
180.14%3.08M
-113.25%-13.89M
2,540.41%101.55M
529.35%1.26M
-109.68%-707K
-939.73%-3.85M
Special income (charges)
--10M
--0
--0
--0
--0
--0
1,395.00%103.6M
64.71%-600K
50.00%-900K
59.09%-900K
-Less：Restructuring and merger&acquisition
----
--0
--0
--0
--0
----
-45.00%4.4M
-64.71%600K
-50.00%900K
-59.09%900K
-Gain on sale of property,plant,equipment
--10M
--0
--0
--0
--0
--0
--108M
--0
--0
--0
Other non- operating income (expenses)
109.12%1.27M
-414.05%-10.54M
-468.03%-6.84M
1,996.89%4.05M
204.61%3.08M
-1,103.38%-13.89M
-117.31%-2.05M
32.05%1.86M
-97.88%193K
-261.04%-2.95M
Income before tax
85.96%105.55M
26.07%188.56M
210.08%19.33M
2,288.50%41.67M
103.18%70.81M
-57.70%56.76M
298.51%149.58M
73.63%-17.56M
95.88%-1.9M
146.19%34.85M
Income tax
185.94%16.89M
160.99%20.92M
93.95%-1.05M
-72.81%1.29M
105.51%14.77M
-55.90%5.91M
171.12%8.02M
-99.50%-17.31M
149.12%4.75M
491.52%7.19M
Net income
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
320.91%141.56M
99.57%-249K
81.77%-6.65M
113.77%27.66M
Net income continuous Operations
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
320.91%141.56M
99.57%-249K
81.77%-6.65M
113.77%27.66M
Minority interest income
Net income attributable to the parent company
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
320.91%141.56M
99.57%-249K
81.77%-6.65M
113.77%27.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
320.91%141.56M
99.57%-249K
81.77%-6.65M
113.77%27.66M
Basic earnings per share
74.07%0.47
17.11%0.89
8,315.09%0.11
625.00%0.21
100.00%0.3
-59.09%0.27
317.14%0.76
99.58%-0.0013
80.00%-0.04
114.29%0.15
Diluted earnings per share
70.37%0.46
16.00%0.87
8,315.09%0.11
625.00%0.21
93.33%0.29
-57.14%0.27
314.29%0.75
99.58%-0.0013
80.00%-0.04
114.29%0.15
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 8.79%648.83M15.42%2.42B20.22%646.21M15.04%581.33M11.52%595.28M14.84%596.42M13.53%2.1B19.50%537.54M23.63%505.34M6.40%533.8M
Operating revenue 8.79%648.83M15.42%2.42B20.22%646.21M15.04%581.33M11.52%595.28M14.84%596.42M13.53%2.1B19.50%537.54M23.63%505.34M6.40%533.8M
Cost of revenue -7.60%125.18M6.45%514.85M6.43%135.48M7.27%124.75M4.03%128.08M15.82%135.47M2.80%483.67M6.30%127.29M12.32%116.29M-3.10%123.13M
Gross profit 13.60%523.65M18.11%1.9B24.49%510.73M17.36%456.58M13.76%467.19M14.55%460.94M17.20%1.61B24.29%410.25M27.47%389.06M9.62%410.67M
Operating expense 11.71%445.19M11.48%1.75B14.35%496.45M10.37%431.01M10.17%408.32M7.40%398.54M8.02%1.57B10.11%434.15M9.52%390.53M2.72%370.62M
Selling and administrative expenses 7.05%225.91M9.75%937.3M11.93%275M3.32%224M9.40%215.34M8.43%211.02M12.46%854M12.91%245.7M18.28%216.8M6.86%196.84M
-Selling and marketing expense ----8.46%488.4M6.90%133.2M9.52%121.9M5.67%115.6M----11.16%450.3M10.17%124.6M14.74%111.3M8.42%109.4M
-General and administrative expense ----11.20%448.9M17.09%141.8M-3.22%102.1M14.07%99.74M----13.94%403.7M15.89%121.1M22.25%105.5M4.96%87.44M
Research and development costs 19.29%204.99M14.96%746.77M19.39%206.25M21.22%191.31M12.12%177.36M6.85%171.85M3.31%649.61M7.24%172.75M-0.03%157.83M-1.81%158.19M
Depreciation amortization depletion -8.76%14.3M-0.96%62.2M-3.18%15.2M-1.26%15.7M0.19%15.62M0.37%15.67M1.45%62.8M0.64%15.7M3.25%15.9M0.61%15.6M
-Depreciation and amortization -8.76%14.3M-0.96%62.2M-3.18%15.2M-1.26%15.7M0.19%15.62M0.37%15.67M1.45%62.8M0.64%15.7M3.25%15.9M0.61%15.6M
Operating profit 25.73%78.46M243.96%158.1M159.74%14.28M1,835.91%25.57M46.98%58.87M99.20%62.4M161.84%45.96M62.79%-23.9M97.13%-1.47M189.73%40.05M
Net non-operating interest income expense 91.97%15.82M1,886.63%41M134.97%11.95M3,637.81%11.96M754.14%8.86M514.90%8.24M142.51%2.06M341.98%5.08M115.66%320K-307.03%-1.35M
Non-operating interest income 62.15%19.37M223.49%58.34M107.16%18.04M214.86%15.74M403.47%12.61M556.21%11.94M72.05%18.03M399.14%8.71M173.62%5M-43.97%2.51M
Non-operating interest expense -4.21%3.55M8.87%16.74M81.47%5.5M-19.23%3.78M-2.69%3.76M-2.71%3.7M4.29%15.38M-6.76%3.03M20.90%4.68M1.10%3.86M
Total other finance cost ----0.17%594K----------------0.00%593K------------
Other net income (expense) 181.13%11.27M-110.38%-10.54M-643.56%-6.84M672.42%4.05M180.14%3.08M-113.25%-13.89M2,540.41%101.55M529.35%1.26M-109.68%-707K-939.73%-3.85M
Special income (charges) --10M--0--0--0--0--01,395.00%103.6M64.71%-600K50.00%-900K59.09%-900K
-Less：Restructuring and merger&acquisition ------0--0--0--0-----45.00%4.4M-64.71%600K-50.00%900K-59.09%900K
-Gain on sale of property,plant,equipment --10M--0--0--0--0--0--108M--0--0--0
Other non- operating income (expenses) 109.12%1.27M-414.05%-10.54M-468.03%-6.84M1,996.89%4.05M204.61%3.08M-1,103.38%-13.89M-117.31%-2.05M32.05%1.86M-97.88%193K-261.04%-2.95M
Income before tax 85.96%105.55M26.07%188.56M210.08%19.33M2,288.50%41.67M103.18%70.81M-57.70%56.76M298.51%149.58M73.63%-17.56M95.88%-1.9M146.19%34.85M
Income tax 185.94%16.89M160.99%20.92M93.95%-1.05M-72.81%1.29M105.51%14.77M-55.90%5.91M171.12%8.02M-99.50%-17.31M149.12%4.75M491.52%7.19M
Net income 74.35%88.66M18.43%167.65M8,282.73%20.38M707.01%40.38M102.57%56.04M-57.90%50.85M320.91%141.56M99.57%-249K81.77%-6.65M113.77%27.66M
Net income continuous Operations 74.35%88.66M18.43%167.65M8,282.73%20.38M707.01%40.38M102.57%56.04M-57.90%50.85M320.91%141.56M99.57%-249K81.77%-6.65M113.77%27.66M
Minority interest income
Net income attributable to the parent company 74.35%88.66M18.43%167.65M8,282.73%20.38M707.01%40.38M102.57%56.04M-57.90%50.85M320.91%141.56M99.57%-249K81.77%-6.65M113.77%27.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 74.35%88.66M18.43%167.65M8,282.73%20.38M707.01%40.38M102.57%56.04M-57.90%50.85M320.91%141.56M99.57%-249K81.77%-6.65M113.77%27.66M
Basic earnings per share 74.07%0.4717.11%0.898,315.09%0.11625.00%0.21100.00%0.3-59.09%0.27317.14%0.7699.58%-0.001380.00%-0.04114.29%0.15
Diluted earnings per share 70.37%0.4616.00%0.878,315.09%0.11625.00%0.2193.33%0.29-57.14%0.27314.29%0.7599.58%-0.001380.00%-0.04114.29%0.15
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg